The company also shared more details of its exit from the TAVR market and the impact of FDA layoffs on product review times.

The maker of patient monitoring devices said the incident will not have a material effect on its updated financial outlook.

IPO drought, the industry is questioning whether the window for medtech public offerings is open following a small burst of ...

Boston Scientific said it would halt worldwide sales of its Acurate devices due to “increased clinical and regulatory ...

Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

The company will compete with a device Boston Scientific acquired for $850 million.

A problem when preparing the devices for use can delay diagnosis or treatment, leading BD to update its instructions.

EndoQuest Robotics completed two procedures with its endoluminal system, while Virtuoso Surgical successfully performed ...

The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of ...

“For too long, Johnson & Johnson has used tying arrangements and other tactics to interfere with fair competition from ...